GHK-Cu and wound healing: what the clinical data actually says
A copper-bound peptide that has been studied for fifty years — and is still mostly understood through animal data and small human trials.
TL;DR
- GHK-Cu is a tiny peptide bound to a copper atom. It has been studied for skin repair and tissue healing since the 1970s.
- Animal studies and small human studies suggest faster wound closure and improved skin quality. Larger controlled trials are limited.
- Topical GHK-Cu has the strongest cosmetic human data. Injectable use rests more on mechanism and animal evidence.
What it is
GHK-Cu stands for glycyl-L-histidyl-L-lysine plus copper. In plain English: a three-amino-acid string that grabs a copper atom and carries it where it can do work in tissue. The body makes GHK on its own, and levels fall sharply with age — about 60% lower at 60 than at 20, by published estimates.
How it works
Picture GHK-Cu as a delivery van for copper. Copper is the spark plug for several enzymes that build collagen and form new blood vessels. By dropping copper at the right location, GHK-Cu turns on tissue-repair machinery: fibroblasts (the cells that lay down collagen) wake up, blood vessels sprout, and inflammation calms down.
In the lab, GHK-Cu changes the activity of about 4,000 genes — most of them tilted toward repair and away from chronic-injury signaling (Pickart et al., 2015).
Who asks about it
People come to this topic when they read that copper peptide is in serums and think: does it actually do anything, or is it skincare marketing? Others have been offered an injectable form by a clinician for post-procedure healing or hair-loss support and want to know if the data lines up.
What the research says
Animal data is consistent: GHK-Cu speeds wound closure, increases collagen, and improves graft survival in multiple species. Human evidence is mixed by route:
Topical cosmetic studies (small randomized trials, 4 to 12 weeks) show measurable improvements in skin density, fine lines, and elasticity — about 2 to 3 in 10 participants notice a clear visible change in 12 weeks. Injectable human data is sparse: case series and small open-label studies, mostly post-surgical or post-laser. Most are studied in the context of physician supervision, not at-home dosing.
What the data does not yet show is a large, blinded, controlled trial comparing GHK-Cu to standard wound care.
What to know before considering it
GHK-Cu is generally well-tolerated in physician-supervised protocols. The most common issues are redness or stinging at the application site. People with copper-metabolism disorders (such as Wilson's disease) should avoid it. Injectable GHK-Cu is not FDA-approved and is prepared by state-licensed 503A compounding pharmacies. Any peptide use requires a clinician evaluation.
The Halftime POV
GHK-Cu sits in a familiar place: real mechanism, real animal data, real human signal, and a research pipeline that has not yet caught up to the popular use. We think the honest read is "promising and worth following" — not over-hyped marketing, and not "ignore it." That distinction is the entire posture of how we discuss peptide science.
Related reading:
- GHK-Cu: what the copper peptide actually is
- Cognitive performance and peptides: what has human data
- Peptide therapy risks and contraindications
FAQ
Q: Does GHK-Cu heal wounds? A: Animal and small human studies suggest GHK-Cu speeds skin and connective-tissue repair. Larger controlled human trials are still limited.
Q: Is GHK-Cu approved for medical use? A: GHK-Cu is widely used in topical cosmetic products. Injectable forms are not FDA-approved and are prepared by state-licensed 503A compounding pharmacies under physician supervision.
Q: Is GHK-Cu safe? A: GHK-Cu is generally well-tolerated in physician-supervised protocols. Reported issues are usually local — redness or stinging at the application site.
Q: Topical or injection — which has more evidence? A: Topical GHK-Cu has the most human cosmetic data. Injectable use is supported mostly by mechanism and animal data, with smaller human reports.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
Frequently asked questions
Does GHK-Cu heal wounds?
Animal and small human studies suggest GHK-Cu speeds skin and connective-tissue repair. Larger controlled human trials are still limited.
Is GHK-Cu approved for medical use?
GHK-Cu is widely used in topical cosmetic products. Injectable forms are not FDA-approved and are prepared by state-licensed 503A compounding pharmacies under physician supervision.
Is GHK-Cu safe?
GHK-Cu is generally well-tolerated in physician-supervised protocols. Reported issues are usually local — redness or stinging at the application site.
Topical or injection — which has more evidence?
Topical GHK-Cu has the most human cosmetic data. Injectable use is supported mostly by mechanism and animal data, with smaller human reports.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.